- ►annals.org [PDF] HM Tsai, L Rice, R Sarode, TW Chow, JL … - Annals of internal medicine, 2000 - Am Coll Physicians Han-Mou Tsai, MD; Lawrence Rice, MD; Ravindra Sarode, MD; Thomas W. Chow, PhD;
and Joel L. Moake, MD ... Background: Thrombotic thrombocytopenic purpura (TTP)
affects 1 in 1600 to 1 in 5000 patients who receive ticlopidine, but little ... Cited by 120 - Related articles - BL Direct - All 4 versions
HANMOU TSAI, WL CHANDLER, R SARODE, … - Pediatric research, 2001 - journals.lww.com Hemolytic uremic syndrome (HUS) usually occurs after in- fection with Shiga
toxin-producing bacteria. Thrombotic throm- bocytopenic purpura, a disorder with
similar clinical manifesta- tions, is associated with deficient activity of ... Cited by 78 - Related articles - BL Direct - All 4 versions
S Fontana, HE Gerritsen, JK Hovinga, M … - British journal of haematology, 2001 - interscience.wiley.com Complete deficiency of von Willebrand factor-cleaving protease (VWF-cp) has
recently been identified as a pathogenetically important factor for thrombotic
thrombocytopenic purpura (TTP). Microangiopathic haemolytic anaemia (MAHA) ... Cited by 46 - Related articles - BL Direct - All 4 versions
Y Asada, A Sumiyoshi, T Hayashi, J Suzumiya … - Thrombosis research, 1985 - ncbi.nlm.nih.gov We collected 23 autopsied cases of thrombotic thrombocytopenic purpura (TTP) and
examined them immunohistochemically and electronmicroscopically to elucidate the
nature of thrombi and subendothelial deposits. The findings were compared ... Cited by 190 - Related articles - All 2 versions
- ►hematologylibrary.org A Veyradier, B Obert, A Houllier, D Meyer, JP … - Blood, 2001 - bloodjournal.hematologylibrary.org Thrombotic microangiopathies (TMAs) are uncommon disorders but the young age of
patients at onset, acute presentation, difficult diagnosis, and sometimes fatal
outcome make them of great interest. TMAs define syndromes of ... Cited by 251 - Related articles - BL Direct - All 4 versions
BJ HUNT, B LÄMMLE, CHF NEVARD, GB … - Thrombosis and haemostasis, 2001 - cat.inist.fr A deficiency of von Willebrand factor(vWF)-cleaving protease, either due to a
congenital deficiency or to the presence of a protease inhibitor of vWF-cleaving
protease has been associated with thrombotic thrombocytopenic purpura(TTP). ... Cited by 43 - Related articles - BL Direct - All 2 versions
- ►hematologylibrary.org - Free from Publisher RM van der Plas, ME Schiphorst, EG Huizinga … - Blood, 1999 - bloodjournal.hematologylibrary.org Thrombotic thrombocytopenic purpura (TTP) after bone marrow transplantation
(BMT) differs from classic TTP in its clinical course and therapy. A
characteristic of classic TTP is the inhibition of a plasma protease that ... Cited by 148 - Related articles - BL Direct - All 5 versions
HM Tsai - American journal of hematology, 2000 - interscience.wiley.com Acute thrombotic thrombocytopenic purpura is a disease with diffuse platelet
thrombi in the microcirculation. Despite plasma exchange therapy, approximately
20 percent of the patients succumb to the disease. A significant number of ... Cited by 42 - Related articles - BL Direct - All 3 versions
- ►bloodjournal.org HM Tsai, II Sussman, D Ginsburg, H Lankhof, … - Blood, 1997 - Am Soc Hematology The susceptibility of recombinant type 2A von Willebrand factor (vWF ) to a
recently identified plasma metalloproteinase and the potential application of
proteolysis inhibition in the treatment of the disease were investigated. ... Cited by 54 - Related articles - BL Direct - All 6 versions
CL Bennett, CJ Davidson, DW Raisch, PD … - Archives of Internal Medicine, 1999 - Am Med Assoc Background One of the most unusual causes of thrombotic thrombocytopenic purpura
(TTP), a life-threatening disease, is ticlopidine hydrochloride, an antiplatelet
agent used to prevent strokes in high-risk populations or following ... Cited by 119 - Related articles - BL Direct - All 6 versions
